Lassa virus NP DEDDh 3'-5' exoribonuclease activity is required for optimal viral RNA replication and mutation control.

bioRxiv

Department of Pathology, Galveston National Laboratory and Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, USA.

Published: December 2023

AI Article Synopsis

  • Lassa virus (LASV) causes Lassa fever and is endemic in West Africa, but there are currently no approved vaccines or antiviral treatments for it.
  • The study reveals that the LASV nucleoprotein (NP) contains an exoribonuclease (ExoN) that not only helps the virus evade the immune response but is also crucial for efficient RNA replication and error control.
  • Using advanced sequencing technology, researchers demonstrated that removing ExoN leads to poor viral growth, increased mutation rates, and structural variations in the viral RNA, highlighting its critical role in maintaining genomic integrity and informing future antiviral strategies.

Article Abstract

Lassa virus (LASV), a mammarenavirus from , is the causative agent of Lassa fever (LF) endemic in West Africa. Currently, there are no vaccines or antivirals approved for LF. The RNA-dependent RNA polymerases (RdRp) of RNA viruses are error-prone. As a negative-sense RNA virus, how LASV copes with errors in RNA synthesis and ensures optimal RNA replication are not well elucidated. LASV nucleoprotein (NP) contains a DEDDH 3'-to-5' exoribonuclease motif (ExoN), which is known to be essential for LASV evasion of the interferon response via its ability to degrade virus-derived double-stranded RNA. Herein, we present evidence that LASV NP ExoN has an additional function important for viral RNA replication. We rescued an ExoN-deficient LASV mutant (ExoN- rLASV) by using a reverse genetics system. Our data indicated that abrogation of NP ExoN led to impaired LASV growth and RNA replication in interferon-deficient cells as compared with wild-type rLASV. By utilizing PacBio Single Molecule, Real-Time (SMRT) long-read sequencing technology, we found that rLASV lacking ExoN activity was prone to producing aberrant viral genomic RNA with structural variations. In addition, NP ExoN deficiency enhanced LASV sensitivity to mutagenic nucleoside analogues in virus titration assay. Next-generation deep sequencing analysis showed increased single nucleotide substitution in ExoN- LASV RNA following mutagenic 5-flurouracil treatment. In conclusion, our study revealed that LASV NP ExoN is required for efficient viral RNA replication and mutation control. Among negative-sense RNA viruses, LASV NP is the first example that a viral protein, other than the RdRp, contributes to reduce errors in RNA replication and maintain genomic RNA integrity. These new findings promote our understanding of the basics of LASV infection and inform antiviral and vaccine development.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120729PMC
http://dx.doi.org/10.1101/2023.04.12.536665DOI Listing

Publication Analysis

Top Keywords

rna replication
24
rna
15
viral rna
12
lasv
12
lassa virus
8
replication mutation
8
mutation control
8
virus lasv
8
rna viruses
8
negative-sense rna
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!